Ann: Change of Director's Interest Notice - PH, page-28

There is a mention of a Funding Arrangement involving an additional 80.2 million shares, indicating possible financing or loan agreements.

The inclusion of 80.2 million additional shares suggests a significant financial maneuver, likely to raise capital, possibly for further development of their product pipeline (such as HER-Vaxx), or other operational needs

It is common for executives, such as Paul Hopper, to hold shares or participate in funding arrangements through private companies or entities like Moreglade Pty Ltd. In this case, Moreglade Pty Ltd likely represents a holding or investment company affiliated with Hopper or related parties.

Moreglade Pty Ltd likely serves as an intermediary or holding entity for shares linked to Imugene’s funding and financial dealings, enabling the company or its directors to participate in structured financial agreements, Moreglade Pty Ltd is referenced in a legally binding document (Appendix 3Y) submitted to the ASX, so calm down whoever is trying to spin a story

This warrants more why, what, how and what next...